Medicine and Dentistry
Adjuvant Chemotherapy
12%
Antiinfective Agent
10%
Biopsy Technique
15%
Bladder
19%
Bladder Cancer
100%
Body Mass Index
7%
Cancer
9%
Cancer Specific Survival
11%
Chronic Kidney Disease
12%
Cisplatin
16%
Clear Cell Renal Cell Carcinoma
27%
Clinical Significance
8%
Cystectomy
35%
Disease
21%
Disease Specific Survival
9%
Diseases
24%
Drive
10%
Glomerular Filtration Rate
30%
Hazard Ratio
11%
Immunity
17%
Infection
7%
Ischemia
7%
Kidney Function
31%
Kidney Tumour
7%
Lymph Node
15%
Lymph Node Metastasis
10%
Malignant Neoplasm
32%
Muscle Invasive Bladder Cancer
23%
Needle Biopsy
12%
Neoadjuvant Chemotherapy
22%
Neoplasm
51%
Nephrectomy
10%
Nephropathy
8%
Nephroureterectomy
38%
Oncologist
8%
Partial Nephrectomy
34%
Pelvis
15%
Prostate Biopsy
16%
Prostate Cancer
22%
Radiation Therapy
10%
Radical Nephrectomy
12%
Recurrent Disease
38%
Retroperitoneal Lymph Node Dissection
9%
Surgeon
10%
Surgical Technique
12%
Tertiary Care
10%
Transitional Cell Carcinoma
65%
Transurethral Resection
9%
Urology
7%
Urothelial Cancer
11%
Keyphrases
Adjuvant Chemotherapy
11%
Antiseptic
10%
Bladder
13%
Bladder Cancer
77%
Cancer-specific Survival
13%
Chemotherapy
9%
Cisplatin
11%
Clinical Outcomes
11%
Clinical Significance
8%
Clinical T1
10%
Cystectomy
18%
Disease-specific Survival
9%
Estimated Glomerular Filtration Rate
18%
Forkhead Box A1 (FOXA1)
21%
Hazard Ratio
12%
High Risk
9%
Histological Variants
16%
Histology
9%
Hospital Admission
8%
Immune Heterogeneity
10%
Lymph Node Metastasis
9%
Medical Oncologist
8%
Molecular Subtypes
17%
Muscle-invasive Bladder Cancer
22%
Neoadjuvant Chemotherapy
21%
Nephrectomy
10%
Nephroureterectomy
36%
Oncologic
9%
Partial Nephrectomy
30%
Pathological Stage
9%
Patient Care
8%
Plastic Heterogeneity
10%
Preoperative Chemotherapy
16%
Prostate Biopsy
16%
Prostate Cancer
18%
Prostate Needle Biopsy
9%
Radical Cystectomy
14%
Radical Nephrectomy
12%
Recurrent Disease
8%
Renal Cell Carcinoma
31%
Renal Function
13%
Restaging
8%
Squamous Differentiation
13%
Systemic Chemotherapy
8%
T1 Bladder Cancer
10%
Tumor
20%
Tumor Size
17%
United States
12%
Upper Tract Urothelial Carcinoma
42%
Urothelial Carcinoma
12%